Evonnect at Mac App Store analyse

App power index: 190 (based on ranks around App Stores today)
Productivity Medical
Developer: Evolutio Care Innovations Ltd
Price: 0 free
Current version: 20.04.24.02, last update: 3 years ago
First release : 01 Mar 2017
App size: 101.75 Mb
4.4 ( 1584 ratings )
follow app ASO analyse

Estimation application downloads and cost

> 4.18k
Monthly downloads
~ $ 1.71k
Estimation App Cost


Evonnect is a proprietary application developed by Evolutio Care Innovations. Evonnect comprises of a number of applications, including enabling NHS compliant secure electronic ophthalmology referrals from primary care to secondary care, the management of ophthalmology patients within a community setting, the ability to run virtual ophthalmology clinics with remote ophthalmologist oversight, telemedicine and remote triage.
Read more
Available in countries
Country Price
Canada free
China free
France free
Germany free
Italy free
Netherlands free
Portugal free
Spain free
Poland free
UK free
India free
Japan free
Korea, Republic Of free
Poland free
Russia free
Turkey free
USA free
Korea, Republic Of free
Ukraine free
Available for devices
iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE, iPhone7, iPhone7Plus, iPad611, iPad612, iPad71, iPad72, iPad73, iPad74, iPhone8, iPhone8Plus, iPhoneX, iPad75, iPad76, iPhoneXS, iPhoneXSMax, iPhoneXR, iPad812, iPad834, iPad856, iPad878, iPadMini5, iPadMini5Cellular, iPadAir3, iPadAir3Cellular, iPodTouchSeventhGen, iPhone11, iPhone11Pro, iPadSeventhGen, iPadSeventhGenCellular, iPhone11ProMax, iPhoneSESecondGen, iPadProSecondGen, iPadProSecondGenCellular, iPadProFourthGen, iPadProFourthGenCellular,